NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease

Detalles Bibliográficos
Autores principales: Thatcher, Gregory RJ, Luo, Jia, VandeVrede, Lawren, Qin, Zhihui, Lee, Sue, Abdelhamid, Ramy, Bennett, Brian M, Jo LaDu, Mary, Tai, Leon, Larson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765650/
http://dx.doi.org/10.1186/2050-6511-14-S1-P72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765650/
http://dx.doi.org/10.1186/2050-6511-14-S1-P72

Ejemplares similares